VGG16 Transfer Learning · MRI Classification

AI-Powered
Brain Tumor
Diagnostics

Upload an MRI scan and receive an instant, high-confidence classification of brain tumors — powered by a fine-tuned VGG16 deep learning model.

🔬 Analyze MRI Scan Explore Model
4
Classification Classes
VGG16
Base Architecture
224px
Input Resolution
ImageNet
Pre-trained Weights
SCROLL
// model architecture

VGG16 Transfer Learning Pipeline

A 16-layer deep CNN pre-trained on 14M ImageNet images, fine-tuned to extract discriminative features from brain MRI scans.

🖼️
MRI Input
128×128 RGB
normalized tensor
→
🔲
Conv Blocks
13 conv layers
ReLU activations
→
🔻
Pooling
5× max-pool
spatial reduction
→
🔗
FC Layers
4096 → 4096
Dropout 0.5
→
📊
Softmax
4-class probability
distribution
01 — FEATURE EXTRACTION
Convolutional Backbone
VGG16's 13 convolutional layers are frozen during training, preserving low-level feature detectors (edges, textures, blobs) learned from 1.2M ImageNet images. These generalize remarkably well to medical imaging.
02 — FINE-TUNING
Custom Classification Head
The original 1000-class ImageNet head is replaced with fully-connected layers tailored for 4-class brain tumor classification. Only the new head and the final conv block are trained on labeled MRI data.
4096 → 4096 → 4
03 — PREPROCESSING
MRI Image Normalization
Images are resized to 128×128, converted to RGB, and normalized using ImageNet mean/std. Data augmentation (rotation, flip, zoom) during training improves robustness to varied MRI acquisition parameters.
μ = [0.485, 0.456, 0.406]
σ = [0.229, 0.224, 0.225]
// classification targets

Four Diagnostic Classes

The model distinguishes between three tumor types and healthy tissue — each with distinct morphological characteristics in MRI.

🔴
Glioma
Arises from glial cells. The most common and aggressive malignant brain tumor, often appearing as an irregular, heterogeneous mass with surrounding edema on MRI T2/FLAIR sequences.
🟡
Meningioma
Originates from the meninges. Usually benign and slow-growing, presenting as a well-defined, homogeneously enhancing extra-axial mass with a dural tail sign on contrast MRI.
🔵
Pituitary
Adenomas of the pituitary gland, located in the sella turcica. Often detected as a sellar or suprasellar mass, frequently causing hormonal imbalance and visual field defects.
🟢
No Tumor
Healthy brain tissue with no detectable neoplastic lesion. Correct negative identification is critical to avoid unnecessary procedures, stress, and healthcare resource consumption.
// clinical impact

Augmenting Radiologist Intelligence

NeuroScan AI is not a replacement for human expertise — it's a high-speed, tireless collaborator that flags potential pathology and quantifies certainty so radiologists can focus their attention where it matters most.

⚡
Rapid Triage
Pre-screen large volumes of MRI scans and surface high-probability positive cases for immediate expert review, compressing diagnostic queues.
🧠
Second Opinion Engine
Provide an independent AI assessment to corroborate or challenge initial radiologist reads, reducing diagnostic error rates.
📉
Reduced Diagnostic Fatigue
AI pre-annotation lets radiologists review flagged areas rather than entire scans, lowering cognitive load during high-volume shifts.
🏥
Resource-Limited Settings
In regions with specialist shortages, AI-assisted screening enables general practitioners to make informed referral decisions before neurologist consultation.
📊
Longitudinal Monitoring
Track tumor class confidence across sequential MRI studies, providing an objective, quantified signal of treatment response or disease progression over time.
🔬
Research & Data Curation
Auto-label large neuroimaging datasets for downstream research, accelerating the training of next-generation oncology models and population-level studies.
⚠️
Regulatory Caveat
This tool is a research prototype. It has not received FDA 510(k) clearance or CE marking. All clinical decisions remain solely the responsibility of licensed medical professionals.